Adrenalin (epinephrine injection, USP)
Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER)
May 2016
WARNINGS AND PRECAUTIONS
Potential for Ophthalmic Injury from Adrenalin® 30 mL multiple-dose vial The Adrenalin® 30 mL...
Source: Drugs.com - Labeling Changes - Category: Drugs & Pharmacology Source Type: alerts